LP
LMR Partners Portfolio holdings
AUM
$6.42B
1-Year Return
24.38%
This Quarter Return
+1.98%
1 Year Return
+24.38%
3 Year Return
+67%
5 Year Return
+89.97%
10 Year Return
+299.91%
AUM
$4.54B
AUM Growth
-$128M
(-2.7%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-27.18%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
1,083
New
295
Increased
91
Reduced
119
Closed
377
Top Buys
| 1 |
TSMC
TSM
|
+$97M |
| 2 |
Marvell Technology
MRVL
|
+$59.5M |
| 3 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$51.1M |
| 4 |
NVIDIA
NVDA
|
+$48.2M |
| 5 |
Meta Platforms (Facebook)
META
|
+$47.8M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$207M |
| 2 |
Kenvue
KVUE
|
+$93.1M |
| 3 |
Unilever
UL
|
+$63M |
| 4 |
WRK
WestRock Company
WRK
|
+$61.9M |
| 5 |
GSK
GSK
|
+$53.6M |
Sector Composition
| 1 | Technology | 28.25% |
| 2 | Healthcare | 10.84% |
| 3 | Communication Services | 6.52% |
| 4 | Consumer Discretionary | 6.44% |
| 5 | Financials | 5.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Simon Property Group
SPG
$58.7B
| $430K | ﹤0.01% |
+2,544
| New | +$430K |
|
377
Pentair
PNR
$17.8B
| $427K | ﹤0.01% |
4,366
-3,121
| -42% | -$305K |
|
378
Natera
NTRA
$23.7B
| $417K | ﹤0.01% |
3,284
-14,524
| -82% | -$1.84M |
|
379
iShares 20+ Year Treasury Bond ETF
TLT
$49.2B
| $416K | ﹤0.01% |
4,245
-120,000
| -97% | -$11.8M |
|
380
Federal Realty Investment Trust
FRT
$8.74B
| $416K | ﹤0.01% |
+3,619
| New | +$416K |
|
381
Confluent
CFLT
$6.82B
| $414K | ﹤0.01% |
20,318
-159,364
| -89% | -$3.25M |
|
382
MasTec
MTZ
$13.7B
| $412K | ﹤0.01% |
+3,347
| New | +$412K |
|
|
RAPP
383
Rapport Therapeutics
RAPP
$1.06B
| $410K | ﹤0.01% |
20,000
-30,000
| -60% | -$614K |
|
384
Cullen/Frost Bankers
CFR
$8.31B
| $402K | ﹤0.01% |
+3,595
| New | +$402K |
|
385
Perspective Therapeutics
CATX
$254M
| $401K | ﹤0.01% |
+30,000
| New | +$401K |
|
386
Novavax
NVAX
$1.26B
| $399K | ﹤0.01% |
+31,613
| New | +$399K |
|
387
Liberty Global Class C
LBTYK
$4.02B
| $398K | ﹤0.01% |
+18,435
| New | +$398K |
|
388
First Hawaiian
FHB
$3.22B
| $392K | ﹤0.01% |
+16,923
| New | +$392K |
|
389
Iovance Biotherapeutics
IOVA
$850M
| $387K | ﹤0.01% |
41,211
-20,000
| -33% | -$188K |
|
|
UCB
390
United Community Banks, Inc.
UCB
$4B
| $383K | ﹤0.01% |
+13,183
| New | +$383K |
|
391
CDW
CDW
$22.2B
| $381K | ﹤0.01% |
+1,684
| New | +$381K |
|
392
Financial Select Sector SPDR Fund
XLF
$54.3B
| $371K | ﹤0.01% |
+8,186
| New | +$371K |
|
393
SL Green Realty
SLG
$4.27B
| $365K | ﹤0.01% |
+5,242
| New | +$365K |
|
394
Axalta
AXTA
$6.8B
| $361K | ﹤0.01% |
+9,971
| New | +$361K |
|
395
Halliburton
HAL
$18.8B
| $360K | ﹤0.01% |
+12,379
| New | +$360K |
|
396
Sunrun
RUN
$3.68B
| $359K | ﹤0.01% |
+19,852
| New | +$359K |
|
397
TScan Therapeutics
TCRX
$106M
| $358K | ﹤0.01% |
71,800
-593,729
| -89% | -$2.96M |
|
398
Independent Bank
INDB
$3.52B
| $351K | ﹤0.01% |
+5,939
| New | +$351K |
|
399
Zevra Therapeutics
ZVRA
$458M
| $347K | ﹤0.01% |
+50,000
| New | +$347K |
|
400
Ferrari
RACE
$85.2B
| $345K | ﹤0.01% |
+734
| New | +$345K |
|